| __timestamp | Bio-Techne Corporation | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 581800000 |
| Thursday, January 1, 2015 | 40853000 | 671900000 |
| Friday, January 1, 2016 | 45187000 | 876700000 |
| Sunday, January 1, 2017 | 53514000 | 857900000 |
| Monday, January 1, 2018 | 55329000 | 822200000 |
| Tuesday, January 1, 2019 | 62413000 | 778200000 |
| Wednesday, January 1, 2020 | 65192000 | 512600000 |
| Friday, January 1, 2021 | 70603000 | 681000000 |
| Saturday, January 1, 2022 | 87140000 | 662200000 |
| Sunday, January 1, 2023 | 92493000 | 910700000 |
| Monday, January 1, 2024 | 96664000 |
Unleashing the power of data
In the ever-evolving landscape of pharmaceuticals and biotechnology, research and development (R&D) investments are pivotal. Over the past decade, Viatris Inc. and Bio-Techne Corporation have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, Viatris Inc. consistently allocated substantial resources, peaking in 2023 with a remarkable 910% increase from its 2014 baseline. In contrast, Bio-Techne Corporation exhibited a steady growth trajectory, culminating in a 212% rise over the same period.
While Viatris Inc. experienced fluctuations, notably a dip in 2020, Bio-Techne's investment showed a more linear progression, reflecting a stable commitment to innovation. The absence of data for Viatris in 2024 suggests a potential shift or reevaluation in their R&D strategy. As these companies forge ahead, their investment patterns offer a glimpse into their future directions and priorities in the competitive biotech arena.
R&D Spending Showdown: Sanofi vs Viatris Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Bio-Techne Corporation
Viatris Inc. or Ascendis Pharma A/S: Who Invests More in Innovation?
Research and Development Investment: Viatris Inc. vs Axsome Therapeutics, Inc.
Research and Development Investment: Viatris Inc. vs CymaBay Therapeutics, Inc.
Comparing Innovation Spending: Viatris Inc. and Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Bio-Techne Corporation vs Verona Pharma plc
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Bio-Techne Corporation and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Protagonist Therapeutics, Inc.
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?